Fast Facts: Sun Pharmaceutical Industries has recalled several lots of lisdexamfetamine dimesylate capsules, a generic form of Vyvanse. The FDA classified the recall as Class II, indicating a low risk of serious health consequences but potential temporary or reversible effects. Patients are advised to check their prescription bottles and contact their healthcare provider or pharmacy for replacements or refunds.